Krishna Institute of Medical Sciences (KIMS) Stock Overview
Provides medical and health care services under the KIMS Hospitals brand in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 6/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
KIMS Community Fair Values
Create NarrativeSee what 25 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Krishna Institute of Medical Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹717.60 |
| 52 Week High | ₹798.40 |
| 52 Week Low | ₹575.80 |
| Beta | 0.13 |
| 1 Month Change | 8.02% |
| 3 Month Change | 20.57% |
| 1 Year Change | 12.98% |
| 3 Year Change | 140.72% |
| 5 Year Change | n/a |
| Change since IPO | 259.90% |
Recent News & Updates
Narrative Update • May 02
KIMS: Planned Equity Raise And Upcoming Results Will Support Future Upside
Analysts have raised their price target for Krishna Institute of Medical Sciences from ₹900 to about ₹968, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Board meeting on March 11, 2026 to evaluate raising funds through issuance of equity shares via one or more qualified institutions placements, a rights issue, other permissible modes, or a combination.
Narrative Update • Apr 18
KIMS: Capital Raising Plans And Postal Ballot Will Shape Steady Outlook
Analysts have kept the price target for Krishna Institute of Medical Sciences steady at ₹650, citing updated assumptions for revenue growth, profit margins and future P/E that are all broadly in line with prior views. What's in the News Board meeting on February 6, 2026 to review and approve unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025 (company filing) Board meeting on March 11, 2026 to evaluate proposals to raise equity capital through one or more qualified institutions placements, a rights issue, other permissible modes, or a combination, subject to required approvals and price determination (company filing) Announcement on March 11, 2026 of a proposed private placement of common shares targeting gross proceeds of ₹15b, with participation expected from qualified institutional buyers and/or other permissible routes, subject to final terms set by the Finance and Investment Committee (company filing) Special or extraordinary shareholders meeting scheduled via postal ballot in India on April 15, 2026 to consider issuing equity shares to investors through a qualified institutions placement for fund raising (company filing) Valuation Changes Fair Value: Maintained at ₹650.0 per share, indicating no change in the central valuation estimate.Narrative Update • Apr 02
KIMS: Fundraising Plans And Postal Ballot Decisions Will Shape Balanced Outlook
Analysts keep the price target for Krishna Institute of Medical Sciences at ₹650, pointing to only small updates in projected revenue growth, profit margin, and future P/E as the basis for maintaining their view. What's in the News Board meeting scheduled for Mar 11, 2026 to consider raising funds through equity issuance, including possible QIP, rights issue, or other permitted modes, subject to shareholder and regulatory approvals (Key Developments).Narrative Update • Mar 18
KIMS: Postal Ballot Transaction And Fundraising Plans Will Shape Balanced Risk Outlook
Analysts have kept the Krishna Institute of Medical Sciences price target steady at ₹650, indicating that only minor tweaks in assumptions for revenue growth, profit margin and future P/E underpin this unchanged view. What's in the News A board meeting is scheduled for Feb 06, 2026 to review and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ended Dec 31, 2025 (company filing).Narrative Update • Mar 04
KIMS: Postal Ballot Related Party Deal Will Drive Bearish Risk Reassessment
Analysts have kept their ₹650 price target for Krishna Institute of Medical Sciences steady, citing only marginal tweaks to assumptions on revenue growth, profit margins, and the future P/E multiple that do not materially change their overall view. What's in the News Board meeting scheduled on Feb 06, 2026 to consider and approve unaudited standalone and consolidated financial results for the third quarter and nine months ended Dec 31, 2025 (company filing).Recent updates
Narrative Update • May 02
KIMS: Planned Equity Raise And Upcoming Results Will Support Future Upside
Analysts have raised their price target for Krishna Institute of Medical Sciences from ₹900 to about ₹968, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Board meeting on March 11, 2026 to evaluate raising funds through issuance of equity shares via one or more qualified institutions placements, a rights issue, other permissible modes, or a combination.Narrative Update • Apr 18
KIMS: Capital Raising Plans And Postal Ballot Will Shape Steady Outlook
Analysts have kept the price target for Krishna Institute of Medical Sciences steady at ₹650, citing updated assumptions for revenue growth, profit margins and future P/E that are all broadly in line with prior views. What's in the News Board meeting on February 6, 2026 to review and approve unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025 (company filing) Board meeting on March 11, 2026 to evaluate proposals to raise equity capital through one or more qualified institutions placements, a rights issue, other permissible modes, or a combination, subject to required approvals and price determination (company filing) Announcement on March 11, 2026 of a proposed private placement of common shares targeting gross proceeds of ₹15b, with participation expected from qualified institutional buyers and/or other permissible routes, subject to final terms set by the Finance and Investment Committee (company filing) Special or extraordinary shareholders meeting scheduled via postal ballot in India on April 15, 2026 to consider issuing equity shares to investors through a qualified institutions placement for fund raising (company filing) Valuation Changes Fair Value: Maintained at ₹650.0 per share, indicating no change in the central valuation estimate.Narrative Update • Apr 02
KIMS: Fundraising Plans And Postal Ballot Decisions Will Shape Balanced Outlook
Analysts keep the price target for Krishna Institute of Medical Sciences at ₹650, pointing to only small updates in projected revenue growth, profit margin, and future P/E as the basis for maintaining their view. What's in the News Board meeting scheduled for Mar 11, 2026 to consider raising funds through equity issuance, including possible QIP, rights issue, or other permitted modes, subject to shareholder and regulatory approvals (Key Developments).Narrative Update • Mar 18
KIMS: Postal Ballot Transaction And Fundraising Plans Will Shape Balanced Risk Outlook
Analysts have kept the Krishna Institute of Medical Sciences price target steady at ₹650, indicating that only minor tweaks in assumptions for revenue growth, profit margin and future P/E underpin this unchanged view. What's in the News A board meeting is scheduled for Feb 06, 2026 to review and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ended Dec 31, 2025 (company filing).Narrative Update • Mar 04
KIMS: Postal Ballot Related Party Deal Will Drive Bearish Risk Reassessment
Analysts have kept their ₹650 price target for Krishna Institute of Medical Sciences steady, citing only marginal tweaks to assumptions on revenue growth, profit margins, and the future P/E multiple that do not materially change their overall view. What's in the News Board meeting scheduled on Feb 06, 2026 to consider and approve unaudited standalone and consolidated financial results for the third quarter and nine months ended Dec 31, 2025 (company filing).Narrative Update • Feb 18
KIMS: Fair View Will Weigh Postal Ballot Risks Against Margin And P/E Shifts
Analysts now set their price target for Krishna Institute of Medical Sciences at ₹650, reduced from a previous fair value estimate of ₹656.16, reflecting updates to their assumptions on the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Board meeting scheduled on Feb 06, 2026 to review and approve unaudited standalone and consolidated financial results for the third quarter and nine months ended Dec 31, 2025 (Key Developments).Analysis Article • Feb 11
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
Investors in Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) had a good week, as its shares rose 5.3% to...Narrative Update • Feb 04
KIMS: Upcoming Results And Related Party Deal Will Support Future Upside
Analysts have maintained their fair value estimate for Krishna Institute of Medical Sciences at ₹900.00. They cite only slight adjustments in revenue growth and profit margin assumptions, along with a marginally lower future P/E multiple, as the reasons for keeping the target unchanged.Narrative Update • Jan 21
KIMS: Stronger Margins And Earnings Visibility Will Support Future Upside Potential
Analysts have kept their fair value estimate for Krishna Institute of Medical Sciences steady at ₹900, citing slightly higher assumed revenue growth of about 31.5% and a modestly stronger profit margin outlook, partly offset by a lower future P/E multiple of about 42.1x. What's in the News A board meeting is scheduled for November 7, 2025 to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2025 (company filing).Narrative Update • Jan 06
KIMS: Fair View Will Weigh Revenue Assumptions Against Margin And P/E Shifts
Analysts have adjusted their price target for Krishna Institute of Medical Sciences to ₹656 from ₹630, reflecting updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News Board meeting scheduled for November 7, 2025 to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2025, providing the next formal look at the company’s reported numbers (company disclosure).Analysis Article • Dec 30
Krishna Institute of Medical Sciences (NSE:KIMS) Takes On Some Risk With Its Use Of Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Narrative Update • Dec 13
KIMS: Higher Margins Are Expected To Drive Stronger Future Share Performance
Narrative Update on Krishna Institute of Medical Sciences Analysts have raised their price target on Krishna Institute of Medical Sciences from ₹885 to ₹900, citing expectations of stronger profit margins and a slightly lower future valuation multiple. These factors more than offset marginally softer revenue growth assumptions and a modestly higher discount rate.Analysis Article • Nov 18
Krishna Institute of Medical Sciences' (NSE:KIMS) Solid Earnings May Rest On Weak Foundations
The recent earnings posted by Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) were solid, but the stock...Analysis Article • Nov 11
Here's Why We Think Krishna Institute of Medical Sciences (NSE:KIMS) Is Well Worth Watching
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analysis Article • Oct 19
Capital Allocation Trends At Krishna Institute of Medical Sciences (NSE:KIMS) Aren't Ideal
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analysis Article • Sep 10
Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Share Price Matching Investor Opinion
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 27x, you may consider...Analysis Article • Aug 23
We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right
Key Insights Krishna Institute of Medical Sciences to hold its Annual General Meeting on 29th of August Salary of...
Narrative Update • Aug 10
New Facilities In India Will Unlock Rising Healthcare Demand
The reduction in Krishna Institute of Medical Sciences' price target reflects a decline in its future P/E ratio, suggesting lower expected earnings multiples despite stable revenue growth forecasts, resulting in the fair value estimate decreasing from ₹820.62 to ₹757.54. What's in the News Board meeting scheduled to consider and approve unaudited standalone and consolidated financial results for Q1 ended June 30, 2025, and other matters.Analysis Article • Aug 10
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
NSEI:KIMS 1 Year Share Price vs Fair Value Explore Krishna Institute of Medical Sciences's Fair Values from the...Analysis Article • Jul 24
Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analysis Article • Jul 02
If EPS Growth Is Important To You, Krishna Institute of Medical Sciences (NSE:KIMS) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • May 19
Krishna Institute of Medical Sciences (NSE:KIMS) Strong Profits May Be Masking Some Underlying Issues
Krishna Institute of Medical Sciences Limited's ( NSE:KIMS ) robust recent earnings didn't do much to move the stock...Analysis Article • May 15
Here's What Analysts Are Forecasting For Krishna Institute of Medical Sciences Limited (NSE:KIMS) After Its Full-Year Results
Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) came out with its yearly results last week, and we wanted to...Analysis Article • Apr 20
Getting In Cheap On Krishna Institute of Medical Sciences Limited (NSE:KIMS) Might Be Difficult
With a price-to-earnings (or "P/E") ratio of 75.2x Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) may be...Analysis Article • Mar 24
Here's What To Make Of Krishna Institute of Medical Sciences' (NSE:KIMS) Decelerating Rates Of Return
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analysis Article • Mar 03
A Look At The Fair Value Of Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Key Insights The projected fair value for Krishna Institute of Medical Sciences is ₹512 based on 2 Stage Free Cash Flow...
New Narrative • Feb 14
Expansion Into Bangalore And Thane With Renowned Doctors Will Strengthen Future Market Presence
Strategic expansions and partnerships are expected to drive revenue growth through increased occupancy and specialized service offerings.Analysis Article • Feb 09
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Investors in Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) had a good week, as its shares rose 4.1% to...Analysis Article • Jan 05
Getting In Cheap On Krishna Institute of Medical Sciences Limited (NSE:KIMS) Is Unlikely
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 32x, you may consider...Analysis Article • Dec 09
We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...Analysis Article • Nov 13
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
A week ago, Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) came out with a strong set of quarterly numbers...Analysis Article • Sep 05
There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump
Despite an already strong run, Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) shares have been powering on...Analysis Article • Aug 23
We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right
Key Insights Krishna Institute of Medical Sciences' Annual General Meeting to take place on 29th of August Total pay...Analysis Article • Aug 10
Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Investors in Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) had a good week, as its shares rose 5.1% to...Analysis Article • Jul 02
Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysis Article • Jun 12
Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 30x, you may consider...Analysis Article • Apr 28
Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analysis Article • Apr 10
We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analysis Article • Feb 29
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Krishna Institute of Medical Sciences Limited's ( NSE:KIMS ) price-to-earnings (or "P/E") ratio of 54.2x might make it...Analysis Article • Feb 08
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
It's shaping up to be a tough period for Krishna Institute of Medical Sciences Limited ( NSE:KIMS ), which a week ago...Analysis Article • Jan 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Key Insights The projected fair value for Krishna Institute of Medical Sciences is ₹1,538 based on 2 Stage Free Cash...Analysis Article • Nov 21
Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...Analysis Article • Aug 23
Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analysis Article • Aug 02
Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Shareholder Returns
| KIMS | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 7.6% | 5.7% | 2.1% |
| 1Y | 13.0% | 13.6% | 8.1% |
Return vs Industry: KIMS exceeded the Indian Healthcare industry which returned 9.3% over the past year.
Return vs Market: KIMS exceeded the Indian Market which returned 6.1% over the past year.
Price Volatility
| KIMS volatility | |
|---|---|
| KIMS Average Weekly Movement | 5.4% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
Stable Share Price: KIMS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: KIMS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 5,264 | Abhinay Bollineni | www.kimshospitals.com |
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal transplant, gynecology, urogynecology, IVF and art, fetal medicine, and obstetrics.
Krishna Institute of Medical Sciences Limited Fundamentals Summary
| KIMS fundamental statistics | |
|---|---|
| Market cap | ₹287.14b |
| Earnings (TTM) | ₹3.01b |
| Revenue (TTM) | ₹36.27b |
95.5x
P/E Ratio7.9x
P/S RatioIs KIMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KIMS income statement (TTM) | |
|---|---|
| Revenue | ₹36.27b |
| Cost of Revenue | ₹14.66b |
| Gross Profit | ₹21.62b |
| Other Expenses | ₹18.61b |
| Earnings | ₹3.01b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
May 15, 2026
| Earnings per share (EPS) | 7.51 |
| Gross Margin | 59.59% |
| Net Profit Margin | 8.29% |
| Debt/Equity Ratio | 123.7% |
How did KIMS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/08 14:32 |
| End of Day Share Price | 2026/05/08 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Krishna Institute of Medical Sciences Limited is covered by 36 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Bhasin | Ambit Capital |
| Ashwin Mehta | Ambit Capital |
| Prashant Nair | Ambit Capital |